The new NCCN guidelines for the management of myelofibrosis

Ruben A. Mesa

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)193-195
Number of pages3
JournalClinical Advances in Hematology and Oncology
Volume15
Issue number3
StatePublished - Mar 1 2017

Fingerprint

Primary Myelofibrosis
Guidelines

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

The new NCCN guidelines for the management of myelofibrosis. / Mesa, Ruben A.

In: Clinical Advances in Hematology and Oncology, Vol. 15, No. 3, 01.03.2017, p. 193-195.

Research output: Contribution to journalComment/debate

@article{e0b98389fd3046de8df863e34b9c37e4,
title = "The new NCCN guidelines for the management of myelofibrosis",
author = "Mesa, {Ruben A.}",
year = "2017",
month = "3",
day = "1",
language = "English (US)",
volume = "15",
pages = "193--195",
journal = "Clinical Advances in Hematology and Oncology",
issn = "1543-0790",
publisher = "Millennium Medical Publishing, Inc.",
number = "3",

}

TY - JOUR

T1 - The new NCCN guidelines for the management of myelofibrosis

AU - Mesa, Ruben A.

PY - 2017/3/1

Y1 - 2017/3/1

UR - http://www.scopus.com/inward/record.url?scp=85015020713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015020713&partnerID=8YFLogxK

M3 - Comment/debate

VL - 15

SP - 193

EP - 195

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

SN - 1543-0790

IS - 3

ER -